HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abdelnoor, M. Articles by Semb, G. Search for Related Content PubMed PubMed Citation Articles by Abdelnoor, M. Articles by Semb, G.

European Journal of Cardio-Thoracic Surgery, Vol 4, 425-430, Copyright © 1990 by European Association for Cardio-thoracic Surgery

ARTICLES

Risk factors for morbidity and mortality in mitral valve replacement

M Abdelnoor, NB Fjeld, K Vaage, JL Svennevig, G Klingen, E Wickstrom, E Sivertssen and G Semb
Department of Cardiovascular Surgery, Ulleval Hospital, University of Oslo, Norway.

Risk factors of operative mortality and long term survival were identified in 219 patients who underwent mitral valve replacement (MVR) using Bjork-Shiley mechanical prostheses. Early mortality was 7.3%. The accumulated follow-up time was 1134 patient-years, and the 5-year survival for the total cohort was 78 +/- 3%. Independent prognostic factors of early mortality were poor NYHA class, which carried a relative risk (RR) of 3.2, and ischaemic aetiology, with a RR of 2.2. Ischaemic aetiology was the sole predictor of heart pump failure requiring intra-aortic balloon pump support (RR = 2.7). Independent risk factors of total mortality (early and late) were male sex (RR = 2.3), NYHA class III-IV (RR = 2.4), presence of mitral regurgitation (RR = 3.2) and relative heart volume (RR = 1.6 for a 800 ml/m2 size compared to a heart of 550 ml/m2). Our results underline the importance of patient-related factors in MVR, and indicate that care is needed in comparing the quality of MVR from different institutions with respect to mortality and morbidity. The results of MVR are palliative rather than curative except in female patients with NYHA class II function and mitral stenosis, in whom cure was attained.

This article has been cited by other articles:

				Y.-Y. Cen, D. D. Glower, K. Landolfo, J. E. Lowe, R. D. Davis, W. G. Wolfe, C. Pieper, and B. Peterson Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 569 - 577. [Abstract] [Full Text] [PDF]

				A. E. Fiane, K. Saatvedt, J. L. Svennevig, O. Geiran, K. Nordstrand, and T. Froysaker The CarboMedics Valve: Midterm Follow-up With Analysis of Risk Factors Ann. Thorac. Surg., October 1, 1995; 60(4): 1053 - 1058. [Abstract] [Full Text]